Stonegate Capital Partners Initiates Coverage on Seabridge Gold Inc. (NYSE: SA)
As of 2Q25, Seabridge Gold maintained a robust financial position, with cash and cash equivalents of $121.4 million, supported by a US$100.2 million equity financing in February 2025 and a $30.5 million flow-through financing in June 2025. Operating costs remain focused on advancing its flagship KSM project and exploration at Iskut, 3 Aces, and Snowstorm. […]
Stonegate Capital Partners Initiates Coverage on Seabridge Gold Inc. (NYSE: SA)
As of 2Q25, Seabridge Gold maintained a robust financial position, with cash and cash equivalents of $121.4 million, supported by a US$100.2 million equity financing in February 2025 and a $30.5 million flow-through financing in June 2025. Operating costs remain focused on advancing its flagship KSM project and exploration at Iskut, 3 Aces, and Snowstorm. […]
Stonegate Capital Partners Initiates Coverage on Provident Financial Services Inc (NYSE: PFS)
Stonegate Capital Partners Initiates Coverage on OS Therapies Inc. (NYSE: OSTX)
OS Therapies advanced meaningful clinical, regulatory, and financial milestones in 2Q25 as it moves closer to bringing OST-HER2 to patients with recurrent, fully resected, pulmonary metastatic osteosarcoma. Importantly, the FDA confirmed that OST-HER2 meets the biological definition of a Regenerative Medicine Advanced Therapy (RMAT) and issued a Biologics License Application (BLA) number in preparation for […]
Stonegate Capital Partners Initiates Coverage on Choice International Ltd. (NSE: CHOICEIN)

Stonegate Capital Partners has initiated coverage on Choice International Ltd.
Stonegate Capital Partners Initiates Coverage on NU Skin Enterprises Inc. (NYSE: NUS)
The Company currently has two strategic initiatives that are expected…
Stonegate Capital Partners Initiates Coverage on Cingulate Inc. (NASDAQ: CING)
Cingulate reported 1Q25 results that highlight continued progress toward the commercial launch of its lead ADHD asset, CTx-1301. The Company remains focused on leveraging its proprietary Precision Timed Release™ (PTR™) platform to address long-standing gaps in ADHD treatment. CTx1301 is uniquely designed to provide once-daily stimulant therapy with rapid onset and sustained efficacy through the […]
Stonegate Capital Partners Initiates Coverage Report On Surf Air Mobility Inc. (NYSE: SRFM)
SRFM’s 1Q26 results showed continued execution under the transformation plan, with revenue of $25.6M at the high end of guidance and up 9% y/y, while adjusted EBITDA loss of $12.3M outperformed guidance for a loss of $15.5M to $13.5M. Results were supported by improved On Demand private charter margins, cost controls across airline operations, and […]
Stonegate Capital Partners Initiates Coverage On GoHealth Inc. (NASDAQ: GOCO)
GoHealth, Inc. delivered a strong fourth quarter in 2024, highlighted by substantial revenue growth and operational efficiencies. Net revenues surged 41% year-over-year to $389.1M, driven by a 67% increase in submissions. The Company posted net income of $58.0M, marking a substantial turnaround from the prior year’s loss, while Adj. EBITDA more than doubled to $117.8M. […]
Stonegate Capital Partners Initiates Coverage on Sky Harbour Group Corporation (NYSE: SKYH)
Sky Harbour continued to demonstrate resilience and growth throughout FY24. The Company successfully navigated economic challenges, including inflation and rising interest rates, while maintaining a strong focus on expanding its portfolio of aviation infrastructure. Key achievements included the completion of several major construction projects, securing new leases, and maintaining robust occupancy rates. The Company’s strategic […]